{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:56:31Z","timestamp":1783086991048,"version":"3.54.6"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,8,15]]},"DOI":"10.2169\/internalmedicine.2970-23","type":"journal-article","created":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T22:11:04Z","timestamp":1704147064000},"page":"2301-2306","source":"Crossref","is-referenced-by-count":1,"title":["Effective Management of Hypertensive Emergencies with Aliskiren Treatment in a Patient before and after Introducing Hemodialysis Secondary to Scleroderma Renal Crisis-like Condition under Corticosteroid Treatment for Sj\u00f6gren Syndrome-associated Multiple Mononeuropathy"],"prefix":"10.2169","volume":"63","author":[{"given":"Osamu","family":"Yamazaki","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Murakawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumika","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Asakawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michito","family":"Nagura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifuru","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Fujigaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Steen VD. Kidney involvement in systemic sclerosis. Presse Med 43: e305-314, 2014.","DOI":"10.1016\/j.lpm.2014.02.031"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Batal I, Domsic RT, Medsger TA, Bastacky S. Scleroderma renal crisis: a pathology perspective. Int J Rheumatol 2010: 543704, 2010.","DOI":"10.1155\/2010\/543704"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Foocharoen C, Tonsawan P, Pongkulkiat P, Anutrakulchai S, Mahakkanukrauh A, Suwannaroj S. Management review of scleroderma renal crisis: an update with practical pointers. Mod Rheumatol 33: 12-20, 2022.","DOI":"10.1093\/mr\/roac028"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. de Zubir\u00eda-Maria A, Florez-Suarez JB, Mendez-Patarroyo P, Quintana-L\u00f3pez G. Pharmacological treatment of scleroderma renalcrisis: a systematic literature review. Rev Colomb Reumatol 27: 111-125, 2020.","DOI":"10.1016\/j.rcreue.2020.01.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65: 2737-2747, 2013.","DOI":"10.1002\/art.38098"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sj\u00f6gren's syndrome (1999): availability and validity. Mod Rheumatol 14: 425-434, 2004.","DOI":"10.1007\/s10165-004-0338-x"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Perzy\u0144ska-Mazan J, Ma\u015bli\u0144ska M, Gasik R. Neurological manifestations of primary Sj\u00f6gren's syndrome. Reumatologia 56: 99-105, 2018.","DOI":"10.5114\/reum.2018.75521"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kowal-Bielecka O, Fransen J, Avouac J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 76: 1327-1339, 2017.","DOI":"10.1136\/annrheumdis-2016-209909"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ramos-Casals M, Nardi N, Brito-Zer\u00f3n P, et al. Atypical autoantibodies in patients with primary Sj\u00f6gren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum 35: 312-321, 2006.","DOI":"10.1016\/j.semarthrit.2005.12.004"},{"key":"10","unstructured":"10. Salliot C, Gottenberg JE, Bengoufa D, Desmoulins F, Miceli-Richard C, Mariette X. Anticentromere antibodies identify patients with Sj\u00f6gren's syndrome and autoimmune overlap syndrome. J Rheumatol 34: 2253-2258, 2007."},{"key":"11","unstructured":"11. Scorza R, Rivolta R, Mascagni B, Berruti V, Bazzi S, Castagnone D, Quarto di Palo F. Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis. J Rheumatol 24: 1944-1948, 1997."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Steen VD, Medsger TA Jr. Long-term outcomes of scleroderma renal crisis. Ann Intern Med 133: 600-603, 2000.","DOI":"10.7326\/0003-4819-133-8-200010170-00010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Penn H, Howie AJ, Kingdon EJ, et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 100: 485-494, 2007.","DOI":"10.1093\/qjmed\/hcm052"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fukasawa H, Furuya R, Ishigaki S, Kinoshita N, Isobe S, Fujigaki Y. Hyponatremia in a patient with scleroderma renal crisis: a potential role of activated renin-angiotensin system. BMC Nephrol 13: 47, 2012.","DOI":"10.1186\/1471-2369-13-47"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Dhaun N, MacIntyre IM, Bellamy CO, Kluth DC. Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney. Am J Kidney Dis 54: 726-731, 2009.","DOI":"10.1053\/j.ajkd.2009.02.015"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Azizi M, Webb R, Nussberger J, Hollenberg NK. Renin inhibition with aliskiren: where are we now, and where are we going? J Hypertens 24: 243-256, 2006.","DOI":"10.1097\/01.hjh.0000202812.72341.99"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gradman AH, Pinto R, Kad R. Current concepts: renin inhibition in the treatment of hypertension. Curr Opin Pharmacol 8: 120-126, 2008.","DOI":"10.1016\/j.coph.2008.01.003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ishimitsu T, Ohta S, Ohno E, et al. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients. Ther Apher Dial 17: 524-531, 2013.","DOI":"10.1111\/1744-9987.12017"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Thomas CP, Nester CM, Phan AC, Sharma M, Steele AL, Lenert PS. Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome. Clin Kidney J 8: 698-670, 2015.","DOI":"10.1093\/ckj\/sfv101"},{"key":"20","unstructured":"20. Steen VD, Mayes MD, Merkel PA. Assessment of kidney involvement. Clin Exp Rheumatol 21: S29-31, 2003."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/16\/63_2970-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T03:29:13Z","timestamp":1723865353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/16\/63_2970-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":20,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2970-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"article-number":"2970-23"}}